Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-27 @ 11:43 PM
Study NCT ID:
NCT02566993
Status:
COMPLETED
Last Update Posted:
2021-10-28
First Post:
2015-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
Sponsor:
PharmaMar
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-24
First Submit QC Date:
None
Study First Post Date:
2015-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-06
Results First Submit QC Date:
None
Results First Post Date:
2021-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-29
Last Update Post Date:
2021-10-28
Last Update Post Date Type:
ACTUAL